ATE429930T1 - Verfahren zur förderung des nukleinsäuretransfers - Google Patents
Verfahren zur förderung des nukleinsäuretransfersInfo
- Publication number
- ATE429930T1 ATE429930T1 AT02741206T AT02741206T ATE429930T1 AT E429930 T1 ATE429930 T1 AT E429930T1 AT 02741206 T AT02741206 T AT 02741206T AT 02741206 T AT02741206 T AT 02741206T AT E429930 T1 ATE429930 T1 AT E429930T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- cells
- complex particles
- gene
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6435—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a connective tissue peptide, e.g. collagen, fibronectin or gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001186320 | 2001-06-20 | ||
JP2001278293 | 2001-09-13 | ||
PCT/JP2002/006137 WO2003000297A1 (fr) | 2001-06-20 | 2002-06-20 | Procede facilitant le transfert d'acides nucleiques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429930T1 true ATE429930T1 (de) | 2009-05-15 |
Family
ID=26617260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02741206T ATE429930T1 (de) | 2001-06-20 | 2002-06-20 | Verfahren zur förderung des nukleinsäuretransfers |
Country Status (12)
Country | Link |
---|---|
US (2) | US8742091B2 (de) |
EP (1) | EP1407787B1 (de) |
JP (1) | JP4081436B2 (de) |
KR (1) | KR100888566B1 (de) |
CN (1) | CN1313158C (de) |
AT (1) | ATE429930T1 (de) |
CA (1) | CA2451603C (de) |
DE (1) | DE60232149D1 (de) |
DK (1) | DK1407787T3 (de) |
ES (1) | ES2324525T3 (de) |
PT (1) | PT1407787E (de) |
WO (1) | WO2003000297A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5118285B2 (ja) * | 2000-06-20 | 2013-01-16 | 大日本住友製薬株式会社 | オリゴヌクレオチド導入製剤 |
DK1407787T3 (da) | 2001-06-20 | 2009-06-02 | Dainippon Sumitomo Pharma Co | Fremgangsmåde til fremme af nukleinsyreoverförsel |
US20080318319A1 (en) * | 2003-12-19 | 2008-12-25 | Yoshiko Minakuchi | Novel Method of Nucleic Acid Transfer |
US20080038824A1 (en) * | 2004-01-29 | 2008-02-14 | National Institute Of Advanced Industrial Science And Technology | Composition and Method for Elevating Gene Transfer Efficiency |
JP2007267602A (ja) * | 2004-06-25 | 2007-10-18 | National Institute Of Advanced Industrial & Technology | 固相上で細胞に核酸を導入し、かつ、この細胞を分化誘導させるための方法および組成物 |
JP4585242B2 (ja) * | 2004-06-29 | 2010-11-24 | 株式会社高研 | 核酸導入用セルトランスフェクションアレイ |
US20090062184A1 (en) * | 2005-03-24 | 2009-03-05 | Dainippon Sumitomo Pharma Co., Ltd. | Fine particulate preparation comprising complex of nucleic acid molecule and collagen |
US7838502B2 (en) * | 2005-05-06 | 2010-11-23 | University Of Massachusetts Medical School | Compositions and methods to modulate H. influenzae pathogenesis |
WO2006126600A1 (ja) * | 2005-05-25 | 2006-11-30 | National University Corporation Nagoya Universtiy | 血管閉塞性疾患用医薬組成物 |
WO2007010620A1 (ja) | 2005-07-22 | 2007-01-25 | Koken Co., Ltd. | 核酸導入用セルトランスフェクションアレイ |
WO2007107774A2 (en) * | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer |
WO2008099906A1 (ja) * | 2007-02-16 | 2008-08-21 | Anges Mg, Inc. | 歯周病、及び外科手術による歯槽骨欠損の治療剤 |
JP5789927B2 (ja) * | 2010-07-30 | 2015-10-07 | Jnc株式会社 | 放射線照射コラーゲン様ペプチドを用いた核酸導入法 |
WO2013102878A2 (en) | 2012-01-05 | 2013-07-11 | Department Of Biotechnology (Dbt) | Fat1 gene in cancer and inflammation |
WO2021041870A1 (en) * | 2019-08-30 | 2021-03-04 | University Of Florida Research Foundation | Aptamer assemblies for protein crosslinking |
WO2022120338A1 (en) * | 2020-12-03 | 2022-06-09 | University Of Florida Research Foundation, Inc. | Aptamer assemblies for protein crosslinking |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5115094B2 (de) * | 1972-11-01 | 1976-05-14 | ||
JPH0712375B2 (ja) * | 1986-11-17 | 1995-02-15 | 株式会社高研 | 移植組成物及びその製造方法 |
US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
JPS6416581A (en) | 1987-07-09 | 1989-01-20 | Rikagaku Kenkyusho | Frozen animal cell and production thereof |
JPH01157388A (ja) | 1987-12-11 | 1989-06-20 | Mitsubishi Heavy Ind Ltd | 形質転換方法 |
US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
US5936035A (en) | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5614587A (en) * | 1988-11-21 | 1997-03-25 | Collagen Corporation | Collagen-based bioadhesive compositions |
JP3187410B2 (ja) | 1989-08-10 | 2001-07-11 | 住友製薬株式会社 | 脳内投与用徐放性製剤 |
JP2789115B2 (ja) | 1989-09-07 | 1998-08-20 | 株式会社高研 | 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法 |
DE69031172T2 (de) | 1989-12-22 | 1998-03-12 | Applied Research Systems | Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
JP2666535B2 (ja) | 1990-08-07 | 1997-10-22 | 東洋紡績株式会社 | 大腸菌のコンピテントセル化緩衝液および大腸菌のコンピテントセル化方法 |
FR2694895B1 (fr) * | 1992-08-20 | 1994-11-10 | Coletica | Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification. |
US5646042A (en) * | 1992-08-26 | 1997-07-08 | Ribozyme Pharmaceuticals, Inc. | C-myb targeted ribozymes |
NZ267291A (en) * | 1993-05-28 | 1997-09-22 | Chiron Corp | Peptide inhibitors of urokinase receptor activity |
AU7655194A (en) * | 1993-09-09 | 1995-03-27 | Schering Aktiengesellschaft | Active principles and gas containing microparticles |
CA2140053C (en) * | 1994-02-09 | 2000-04-04 | Joel S. Rosenblatt | Collagen-based injectable drug delivery system and its use |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US5583034A (en) * | 1994-02-22 | 1996-12-10 | La Jolla Institute For Allergy And Immunology | Enhancement of adoptosis using antisense oligonucleotides |
US5844107A (en) * | 1994-03-23 | 1998-12-01 | Case Western Reserve University | Compacted nucleic acids and their delivery to cells |
US5563255A (en) * | 1994-05-31 | 1996-10-08 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
EP0769063A1 (de) * | 1994-06-27 | 1997-04-23 | The Johns Hopkins University | Gezielte freigabe genetischen materials |
NO180167C (no) * | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
GB9422495D0 (en) | 1994-11-08 | 1995-01-04 | Medical Res Council | DNA transfer method |
JP3867160B2 (ja) | 1995-07-03 | 2007-01-10 | 大日本住友製薬株式会社 | 遺伝子製剤 |
IL122802A0 (en) | 1995-07-03 | 1998-08-16 | Koken Kk | Gene preparations |
US6998268B2 (en) * | 1995-07-03 | 2006-02-14 | Dainippon Sumitomo Pharma Co. Ltd. | Gene preparations |
NZ320006A (en) | 1995-10-23 | 2001-12-21 | Meditech Res Ltd | An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction |
DE69636122T2 (de) | 1995-11-13 | 2006-12-07 | Takara Bio Inc., Otsu | Verfahren zum gentransfer in zielzellen mit einem retrovirus |
ES2420106T3 (es) * | 1995-12-18 | 2013-08-22 | Angiodevice International Gmbh | Composiciones de polímeros reticulados y métodos para su uso |
CA2248538A1 (en) * | 1996-03-14 | 1997-09-18 | The Immune Response Corporation | Targeted delivery of genes encoding interferon |
US5874006A (en) * | 1996-10-31 | 1999-02-23 | Matrix Pharmaceutical, Inc. | Aseptic collagen concentration process |
US6042820A (en) * | 1996-12-20 | 2000-03-28 | Connaught Laboratories Limited | Biodegradable copolymer containing α-hydroxy acid and α-amino acid units |
US6218112B1 (en) * | 1996-12-23 | 2001-04-17 | Cobra Therapeutics Limited | Optimization of gene delivery and gene delivery system |
US6524613B1 (en) * | 1997-04-30 | 2003-02-25 | Regents Of The University Of Minnesota | Hepatocellular chimeraplasty |
IT1293088B1 (it) | 1997-07-10 | 1999-02-11 | Isi Ist Sierovaccinogeno Ital | Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in |
JPH11127843A (ja) | 1997-10-27 | 1999-05-18 | Sumitomo Bakelite Co Ltd | 培養用着色容器 |
TW572758B (en) | 1997-12-22 | 2004-01-21 | Sumitomo Pharma | Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives |
AU2868099A (en) * | 1998-02-13 | 1999-08-30 | Selective Genetics, Inc. | Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby |
EP1078639A4 (de) | 1998-05-22 | 2004-10-06 | Sumitomo Pharma | Stabile genherstellung |
JP3587438B2 (ja) | 1999-01-14 | 2004-11-10 | 住友ベークライト株式会社 | 培養細胞凍結用マルチウェルプレート |
JP3557924B2 (ja) * | 1998-12-10 | 2004-08-25 | トヨタ自動車株式会社 | 電動機制御装置及び電動機制御方法 |
TR199901199A3 (tr) | 1999-05-31 | 2001-09-21 | Kocagoez Tanil | Bakteri transformasyon kiti |
JP2001199903A (ja) | 1999-11-09 | 2001-07-24 | Eizo Mori | 核酸含有複合体 |
EP1274410A2 (de) * | 2000-03-31 | 2003-01-15 | Trustees Of Boston University | Verwendung von lokal aplizierten dna-fragmenten |
JP2001335512A (ja) | 2000-05-23 | 2001-12-04 | Yamanouchi Pharmaceut Co Ltd | 遺伝子導入のための微粒子 |
JP5118285B2 (ja) * | 2000-06-20 | 2013-01-16 | 大日本住友製薬株式会社 | オリゴヌクレオチド導入製剤 |
JP2002325572A (ja) * | 2000-12-25 | 2002-11-12 | Univ Osaka | 外来物質の導入方法 |
DK1407787T3 (da) | 2001-06-20 | 2009-06-02 | Dainippon Sumitomo Pharma Co | Fremgangsmåde til fremme af nukleinsyreoverförsel |
JP4022614B2 (ja) | 2002-03-25 | 2007-12-19 | 国立大学法人大阪大学 | 新規なバイオビーズの作製方法 |
ITMI20021444A1 (it) | 2002-07-01 | 2004-01-02 | Danieli Off Mecc | Tubo forma spire |
US7148342B2 (en) * | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
US20060030534A1 (en) * | 2002-09-04 | 2006-02-09 | Gabriele Dorn | Treatment of neurological disorders by dsrna administration |
JPWO2004026343A1 (ja) * | 2002-09-20 | 2006-01-12 | 住友製薬株式会社 | 部位特異的遺伝子変換促進剤および遺伝子疾患治療剤 |
WO2004042024A2 (en) * | 2002-11-01 | 2004-05-21 | The Trustees Of The University Of Pennsylvania | COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
ATE477337T1 (de) * | 2003-01-16 | 2010-08-15 | Univ Pennsylvania | Zusammensetzungen und verfahren zur sirna-hemmung von icam-1 |
US8227434B1 (en) * | 2003-11-04 | 2012-07-24 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Materials and methods for treating oncological disorders |
JP4989456B2 (ja) * | 2004-02-26 | 2012-08-01 | ベイラー リサーチ インスティテュート | 関節炎の全身処置のための組成物および方法 |
NZ553987A (en) * | 2004-09-28 | 2011-01-28 | Quark Pharmaceuticals Inc | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases |
CA2584459A1 (en) * | 2004-10-22 | 2006-04-27 | Universite Laval | Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
US7585848B2 (en) * | 2005-01-11 | 2009-09-08 | Rush University Medical Center | Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc |
WO2007082899A1 (en) * | 2006-01-17 | 2007-07-26 | Vib Vzw | Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
US8106024B2 (en) * | 2006-06-16 | 2012-01-31 | Taisho Pharmaceutical Co., Ltd. | Method of treating cancer with an RPN2 gene expression inhibitor |
CN101490253A (zh) * | 2006-07-21 | 2009-07-22 | 赛伦斯治疗公司 | 用于抑制蛋白激酶3表达的方法 |
WO2008028085A2 (en) * | 2006-08-30 | 2008-03-06 | The Board Of Trustees Of The University Of Illinois | Modulation of mlck-l expression and uses thereof |
US7902167B2 (en) * | 2006-10-02 | 2011-03-08 | Aprea Ab | Compounds and methods for down-regulating Wrap53 protein by RNA interference |
US7812002B2 (en) * | 2007-03-21 | 2010-10-12 | Quark Pharmaceuticals, Inc. | Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer |
CA2782728A1 (en) * | 2009-12-04 | 2011-06-09 | Opko Ophthalmics, Llc | Compositions and methods for inhibition of vegf |
-
2002
- 2002-06-20 DK DK02741206T patent/DK1407787T3/da active
- 2002-06-20 PT PT02741206T patent/PT1407787E/pt unknown
- 2002-06-20 EP EP02741206A patent/EP1407787B1/de not_active Expired - Lifetime
- 2002-06-20 CA CA2451603A patent/CA2451603C/en not_active Expired - Fee Related
- 2002-06-20 JP JP2003506939A patent/JP4081436B2/ja not_active Expired - Lifetime
- 2002-06-20 CN CNB028164008A patent/CN1313158C/zh not_active Expired - Fee Related
- 2002-06-20 WO PCT/JP2002/006137 patent/WO2003000297A1/ja active Application Filing
- 2002-06-20 AT AT02741206T patent/ATE429930T1/de active
- 2002-06-20 DE DE60232149T patent/DE60232149D1/de not_active Expired - Lifetime
- 2002-06-20 US US10/481,511 patent/US8742091B2/en active Active
- 2002-06-20 KR KR1020037016627A patent/KR100888566B1/ko not_active IP Right Cessation
- 2002-06-20 ES ES02741206T patent/ES2324525T3/es not_active Expired - Lifetime
-
2009
- 2009-09-04 US US12/554,846 patent/US20100081202A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040266004A1 (en) | 2004-12-30 |
CN1313158C (zh) | 2007-05-02 |
DE60232149D1 (de) | 2009-06-10 |
PT1407787E (pt) | 2009-07-07 |
EP1407787A4 (de) | 2006-02-08 |
CA2451603A1 (en) | 2003-01-03 |
JPWO2003000297A1 (ja) | 2005-04-07 |
DK1407787T3 (da) | 2009-06-02 |
EP1407787B1 (de) | 2009-04-29 |
CN1622831A (zh) | 2005-06-01 |
EP1407787A1 (de) | 2004-04-14 |
KR100888566B1 (ko) | 2009-03-12 |
ES2324525T3 (es) | 2009-08-10 |
US8742091B2 (en) | 2014-06-03 |
CA2451603C (en) | 2012-07-10 |
US20100081202A1 (en) | 2010-04-01 |
JP4081436B2 (ja) | 2008-04-23 |
WO2003000297A1 (fr) | 2003-01-03 |
KR20040023622A (ko) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE429930T1 (de) | Verfahren zur förderung des nukleinsäuretransfers | |
JP6986103B2 (ja) | 高スループット単一細胞トランスクリプトームライブラリーならびにその作製方法および使用方法 | |
Cheema et al. | Mechanical signals and IGF‐I gene splicing in vitro in relation to development of skeletal muscle | |
RU2688485C2 (ru) | Способы получения библиотек двухцепочечных днк и способы секвенирования для идентификации метилированных цитозинов | |
Liu et al. | Effect of 3D scaffold and dynamic culture condition on the global gene expression profile of mouse embryonic stem cells | |
CA2501280C (en) | Cell culture | |
DePamphilis | Replication origins in metazoan chromosomes: fact or fiction? | |
Herbert et al. | Chicken double-stranded RNA adenosine deaminase has apparent specificity for Z-DNA. | |
AU2006306809B2 (en) | Methods of specifying mesodermal, endodermal and mesoendodermal cell fates | |
US20170356039A1 (en) | Vesicular linker and uses thereof in nucleic acid library construction and sequencing | |
US7361493B1 (en) | Production of urokinase in a three-dimensional cell culture | |
CN102395672A (zh) | 用于干细胞培养的方法和组合物 | |
Diederichs et al. | Differential regulation of SOX9 protein during chondrogenesis of induced pluripotent stem cells versus mesenchymal stromal cells: a shortcoming for cartilage formation | |
Rood et al. | Genomic organization and chromosome localization of the human cathepsin K gene (CTSK) | |
Schwartz et al. | Stimulatory effect of okadaic acid, an inhibitor of protein phosphatases, on nuclear envelope breakdown and protein phosphorylation in mouse oocytes and one-cell embryos | |
Haudenschild et al. | Differential expression of multiple genes during articular chondrocyte redifferentiation | |
Robinson et al. | MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research | |
Kunitomi et al. | Improved Sendai viral system for reprogramming to naive pluripotency | |
GB2409274A (en) | Trap-tagging: a novel method for the identification and purification of RNA-protein complexes | |
Kay Sinclair et al. | Effect of osteoclast co-culture on the differentiation of human mesenchymal stem cells grown on bone graft granules | |
Yamaguchi et al. | Cloning and expression of cDNA encoding a human ubiquitin-conjugating enzyme similar to the Drosophila bendless gene product | |
Cao et al. | Histone Arginine Methyltransferase CARM1-Mediated H3R26me2 Is Essential for Morula-to-Blastocyst Transition in Pigs | |
Helland et al. | Properties and mechanism of action of eukaryotic 3-methyladenine-DNA glycosylases | |
CN105969878B (zh) | 长链非编码rna enst00000430247的应用 | |
CN105925706B (zh) | 长链非编码rna loc100506530的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1407787 Country of ref document: EP |
|
EEIH | Change in the person of patent owner |